Jürgen Krauß
Immunologe
Geboren:
1960
Hat mitgewirkt an:
-
Chimärisierung der monoklonalen Antikörper Ber-H2 (Anti-CD30) und TÜK3 (Anti-CD34)
-
Immunotherapy Development to Target Herpes Simplex Virus Infections
-
RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab
-
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced...